Health · 1 sources covering this

STAT+: Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer

An experimental drug combination led to tumor responses in 82% of patients with a certain type of advanced pancreatic cancer, Tango Therapeutics reported.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer
An experimental drug combination led to tumor responses in 82% of patients with a certain type of advanced pancreatic cancer, Tango Therapeutics reported.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/8ec947322a9504af1052d7a5a2a08b12a70f0528"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer"></iframe>

STAT+: Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer

How 1 sources are covering this

STAT+: Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer

More from Health

What if you gave yourself a day to cancel all the plans you dread?

Shopping for an ACA Plan This Year? Here’s What You Need To Know

GOP Congressman in California Swing-District Race Defends Vote for Medicaid Cuts

Medicaid at Risk for Hundreds of Thousands of Lawfully Present Immigrants

Reader

Trust & legal

Across the network